Epidemiological evidence against a role for C-reactive protein causing leptin resistance

被引:5
|
作者
Rutter, M. K. [1 ,2 ]
Sattar, N. [3 ]
Tajar, A. [4 ,5 ]
O'Neill, T. W. [6 ]
Lee, D. M. [6 ]
Bartfai, G. [7 ]
Boonen, S. [8 ,9 ]
Casanueva, F. F. [10 ,11 ]
Finn, J. D. [6 ]
Forti, G. [12 ]
Giwercman, A. [13 ]
Han, T. S. [14 ]
Huhtaniemi, I. T. [15 ]
Kula, K. [16 ]
Lean, M. E. J. [17 ]
Pendleton, N. [18 ]
Punab, M. [19 ]
Silman, A. J. [6 ]
Vanderschueren, D. [20 ]
Lowe, G. [21 ]
O'Rahilly, S. [22 ]
Morris, R. W. [23 ]
Wu, F. C. [1 ,24 ]
Wannamethee, S. G. [23 ]
机构
[1] Univ Manchester, Endocrinol & Diabet Grp, Dev Biomed Res Grp, Manchester M13 9PT, Lancs, England
[2] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Diabet Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[3] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[4] Univ Oxford, Ctr Stat Med, Oxford, England
[5] Oxford Biomed Res Ctr, Oxford, England
[6] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England
[7] Albert Szent Gyorgy Med Univ, Dept Obstet Gynaecol & Androl, Szeged, Hungary
[8] Katholieke Univ Leuven, Div Gerontol & Geriatr, Dept Expt Med, Louvain, Belgium
[9] Katholieke Univ Leuven, Ctr Musculoskeletal Res, Dept Expt Med, Louvain, Belgium
[10] Univ Santiago de Compostela, CHUS, Dept Med, Santiago De Compostela, Spain
[11] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain
[12] Univ Florence, Dept Clin Physiopathol, Androl Unit, Florence, Italy
[13] Lund Univ, Reprod Med Ctr, Malmo Univ Hosp, Malmo, Sweden
[14] Royal Free Hosp, Dept Endocrinol, Royal Free & Univ Coll Hosp Med Sch, London NW3 2QG, England
[15] Univ London Imperial Coll Sci Technol & Med, Dept Reprod Biol, London, England
[16] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland
[17] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland
[18] Univ Manchester, Hope Hosp, Salford M6 8HD, Lancs, England
[19] Tartu Univ Clin, Androl Unit, United Labs, Tartu, Estonia
[20] Katholieke Univ Leuven, Dept Androl & Endocrinol, Louvain, Belgium
[21] Univ Glasgow, Royal Infirm, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[22] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England
[23] UCL, Sch Med, Dept Primary Care & Populat Hlth, London W1N 8AA, England
[24] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Endocrinol, Manchester, Lancs, England
关键词
RISK; ADIPOSITY; MEN;
D O I
10.1530/EJE-12-0348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: It has been suggested that elevated levels of C-reactive protein (CRP) might interfere with leptin signalling and contribute to leptin resistance. Our aim was to assess whether plasma levels of CRP influence leptin resistance in humans, and our hypothesis was that CRP levels would modify the cross-sectional relationships between leptin and measures of adiposity. Design and methods: We assessed four measures of adiposity: BMI, waist circumference, fat mass and body fat (%) in 2113 British Regional Heart Study (BRHS) men (mean (S.D.) age 69 (5) years), with replication in 760 (age 69 (6) years) European Male Ageing Study (EMAS) subjects. Results: In BRHS subjects, leptin correlated with CRP (Spearman's r=0.22, P<0.0001). Leptin and CRP correlated with all four measures of adiposity (r value range: 0.22-0.57, all P<0.0001). Age-adjusted mean levels for adiposity measures increased in relation to leptin levels, but CRP level did not consistently influence the beta-coefficients of the regression lines in a CRP-stratified analysis. In BRHS subjects, the BMI vs leptin relationship demonstrated a weak statistical interaction with CRP (P=0.04). We observed no similar interaction in EMAS subjects and no significant interactions with other measures of adiposity in BRHS or EMAS cohorts. Conclusion: We have shown that plasma CRP has little influence on the relationship between measures of adiposity and serum leptin levels in these middle-aged and elderly male European cohorts. This study provides epidemiological evidence against CRP having a significant role in causing leptin resistance. European Journal of Endocrinology 168 101-106
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条
  • [1] Induction of leptin resistance through direct interaction of C-reactive protein with leptin
    Chen, K
    Li, FH
    Li, J
    Cai, HB
    Strom, S
    Bisello, A
    Kelley, DE
    Friedman-Einat, M
    Skibinski, GA
    McCrory, MA
    Szalai, AJ
    Zhao, AZ
    NATURE MEDICINE, 2006, 12 (04) : 425 - 432
  • [2] Induction of leptin resistance through direct interaction of C-reactive protein with leptin
    Ke Chen
    Fanghong Li
    Ji Li
    Hongbo Cai
    Steven Strom
    Alessandro Bisello
    David E Kelley
    Miriam Friedman-Einat
    Gregory A Skibinski
    Mark A McCrory
    Alexander J Szalai
    Allan Z Zhao
    Nature Medicine, 2006, 12 : 425 - 432
  • [3] Role of C Reactive Protein (CRP) in Leptin Resistance
    Hribal, Marta Letizia
    Fiorentino, Teresa Vanessa
    Sesti, Giorgio
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (04) : 609 - 615
  • [4] Insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein and metabolic syndrome
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    ANNALS OF THORACIC MEDICINE, 2011, 6 (04)
  • [5] C-Reactive Protein: Clinical and Epidemiological Perspectives
    Salazar, Juan
    Martinez, Maria Sofia
    Chavez, Mervin
    Toledo, Alexandra
    Anez, Roberto
    Torres, Yaquelin
    Apruzzese, Vanessa
    Silva, Carlos
    Rojas, Joselyn
    Bermudez, Valmore
    CARDIOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [6] ROLE OF C-REACTIVE PROTEIN IN ENDOTOXIN INDUCED RESISTANCE TO INFECTION
    HARPER, JM
    PATTERSO.LT
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1965, 23 (03) : 649 - &
  • [7] Evidence of common genetic regulation of C-reactive protein and insulin resistance
    Guo, Xiuqing
    Chen, Yii-Der I.
    Xiang, Anny
    Fang, Belle
    Hsueh, Willa A.
    Buchanan, Thomas A.
    Raffel, Leslie J.
    Rotter, Jerome I.
    DIABETES, 2008, 57 : A270 - A270
  • [8] A ROLE FOR C-REACTIVE PROTEIN IN THE COMPLEMENT MEDIATED OPSONIZATION OF PNEUMOCOCCI BY C-REACTIVE PROTEIN
    EDWARDS, KM
    MOLD, C
    LINT, TF
    GEWURZ, H
    CLINICAL RESEARCH, 1980, 28 (04): : A735 - A735
  • [9] THE ROLE OF C-REACTIVE PROTEIN IN ATHEROTHROMBOSIS
    Jialal, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes
    McFadyen, James D.
    Kiefer, Jurij
    Braig, David
    Loseff-Silver, Julia
    Potempa, Lawrence A.
    Eisenhardt, Steffen Ulrich
    Peter, Karlheinz
    FRONTIERS IN IMMUNOLOGY, 2018, 9